WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

REVIEW ARTICLE ON SULFONAMIDE DERIVATIVE AS DPP-4 INHIBITOR

Dr. Shailaja B. Jadhav* and Megha Salve

ABSTRACT

Diabetes is chronic metabolic disorder which growing fast ground world. Dipeptidyl peptidase IV (DPP4) inhibitors are proven in the treatment of type 2 diabetes. DPP-4 is a target during controlling diabetes glycemic control. DPP‐4 inhibitors have been shown to be generally well tolerated, with a low risk of hypoglycemia and neutral weight gain, and have anticipated long‐term beneficial effects on β‐cell function. A number of DPP-4 inhibitor develop rapidly for management of type-2 diabetes. This article review development of synthetic sulphonamide derivative as a DPP-4 inhibitor from 2004 to 2017 and provide SAR, biological activities against DPP-4and selectivity over DPP-8/DPP-9.

Keywords: DPP4 inhibitors, Sulfonamide derivative, type 2 diabetes.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More